UBS Group
ARTL icon

UBS Group’s Artelo Biosciences ARTL Stock Holding History

UBS Group’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,207
Closed -$41K – 10456
2025
Q4 		$41K Buy
11,207
+11,137
+15,910% +$86.4K ﹤0.01% 7322
2025
Q3 		$959 Buy
70
+40
+133% +$1.23K ﹤0.01% 9482
2025
Q2 		$1.18K Sell
30
-680
-96% -$12.6K ﹤0.01% 9666
2025
Q1 		$11.2K Sell
710
-29
-4% -$583 ﹤0.01% 8566
2024
Q4 		$14.1K Buy
+739
New +$14.9K ﹤0.01% 8112
2024
Q2 		– Sell
-7
Closed -$185 – 9497
2024
Q1 		$185 Buy
+7
New +$186 ﹤0.01% 8748
2023
Q4 		– Sell
-6
Closed -$164 – 9280
2023
Q3 		$164 Buy
+6
New +$200 ﹤0.01% 8758
2023
Q2 		– Sell
-132
Closed -$5.52K – 8882
2023
Q1 		$5.52K Sell
132
-38
-22% -$1.93K ﹤0.01% 8030
2022
Q4 		$8.82K Sell
170
-51
-23% -$2.66K ﹤0.01% 8724
2022
Q3 		$14K Buy
221
+40
+22% +$3.22K ﹤0.01% 7891
2022
Q2 		$16K Buy
181
+113
+166% +$11.1K ﹤0.01% 7171
2022
Q1 		$8K Buy
+68
New +$7.81K ﹤0.01% 8651
2021
Q3 		– Sell
-135
Closed -$43K – 9504
2021
Q2 		$43K Buy
135
+77
+133% +$26.3K ﹤0.01% 6566
2021
Q1 		$26K Buy
+58
New +$24.8K ﹤0.01% 7123
2020
Q2 		– Sell
-3
Closed -$1K – 7918
2020
Q1 		$1K Buy
+3
New +$1.34K ﹤0.01% 7728
2019
Q4 		– Sell
-13
Closed -$8K – 8091
2019
Q3 		$8K Buy
+13
New +$9.91K ﹤0.01% 7263

Other funds holding ARTL

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

UBS Group's ARTL Position: Q1 2026 in Review

UBS Group sold out of Artelo Biosciences (ARTL) in Q1 2026, closing a stake of 11,207 shares — an estimated $41K sold.

UBS Group first reported a position in ARTL in Q3 2019 and held it in 16 quarters. The position peaked at $43K in Q2 2021. 11 funds tracked by Wall St. Rank hold ARTL as of Q1 2026.

  • UBS Group reported no remaining Artelo Biosciences position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 11,207 Artelo Biosciences shares in Q1 2026, an estimated $41K.
  • UBS Group first reported a position in Artelo Biosciences in Q3 2019 and held it in 16 quarters.
  • UBS Group's Artelo Biosciences position peaked at $43K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Artelo Biosciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.